Murine α-N-acetylgalactosaminidase: Isolation and expression of a full- length cDNA and genomic organization: Further evidence of an α-galactosidase gene family

Molecular Genetics and Metabolism

Volumn 65, Issue 2, 1998, Pages 165-173

  Wang, Anne M ^a   Ioannou, Yiannis A ^a   Zeidner, Ken M ^a   Desnick, Robert J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cloning; Fabry disease; Gene targeting; Schindler disease; galactosidase; N acetylgalactosaminidase

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA N ACETYLGALACTOSAMINIDASE; COMPLEMENTARY DNA; HYDROLASE; LYSOSOME ENZYME;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ANALYSIS; GENE STRUCTURE; HUMAN; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; STRUCTURAL GENE;

EID: 0032192394     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2750     Document Type: Article

References (39)

1. 1. Kint J. On the existence and the enzymatic interconversion of α-galactosidase in human organs. Arch Int Phys Biochem 79:633-634, 1971.
2. 2. Beutler E, Kuhl W. Biochemical and electrophoretic studies of α-galactosidase in normal man, in patients with Fabry's disease, and in Equidae. Am J Hum Genet 24:237-249, 1972.
3. 3. Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W. Fabry's disease: Enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 81: 157-171, 1973.
4. 4. Crawhall JC, Banfalvi M. Fabry's disease: Differentiation between two forms of α-galactosidase by myoinsositol. Science 177:527-528, 1972.
5. 5. Rietra PJ, Van den Bergh FA, Tager JM. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote. Clin Chim Acta 62:401-413, 1975.
6. 6. Ho MW, Beutler S, Tennant L, O'Brien JS. Fabry's disease: Evidence for a physically altered α-galactosidase. Am J Hum Genet 24:256-266, 1972.
7. 7. Romeo G, Childs B, Migeon B. Genetic heterogeneity of α-galactosidase in Fabry's disease. FEBS Lett 27:161-166, 1972.
8. 8. Wood S, Nadler HL. Fabry's disease: Absence of an α-galactosidase isozyme. Am J Hum Genet 24:250-255, 1972.
9. 9. Beutler E, Kuhl W. Purification and properties of human α-galactosidases. J Biol Chem 247:7195-7200, 1972.
10. 10. Dean KJ, Sung SS, Sweeley CC. The identification of α-galactosidase B from human liver as an α-N-acetylgalactosaminidase. Biochem Biophys Res Commun 77:1411-1417, 1977.
11. 11. Kusiak JW, Quirk JM, Brady RO. Purification and properties of the two major isozymes of α-galactosidase from human placenta. J Biol Chem 253:184-190, 1978.
12. 12. Bishop DF, Desnick RJ. Affinity purification of α-galactosidase A from human spleen, placenta, and plasma with elimination of pyrogen contamination. Properties of the purified splenic enzyme compared to other forms. J Biol Chem 256: 1307-1316, 1981.
13. 13. Mandel J, Willard H, Nussbaum R, Romeo G, Puck J, Davies K. Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet 51:384-437, 1989.
14. 14. Schram AW, Hamers MN, Tager JM. The identity of alpha-galactosidase B from human liver. Biochim Biophys Acta 482:138-144, 1977.
15. 15. Geurts van Kessel A, Westerveld A, de Groot P, Meera Khan P, Hagemeijer A. Regional localization of the genes coding for human ACO2, ARSA, and NAGA on chromosome 22. Cytogenet Cell Genet 28:169-172, 1980.
16. 16. Bishop DF, Calhoun DH, Bernstein HS, Hantzopoulos P, Quinn M, Desnick RJ. Human α-galactosidase A: Nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc Natl Acad Sci USA 83:4859-4863, 1986.
17. 17. Bishop DF, Kornereich R, Eng CM, Ioannou YA, Fitzmaurice TF, Desnick RJ. Human α-galactosidase: Characterization and eukaryotic expression of the full-length cDNA and structural organization of the gene. In Lipid Storage Disorders (Salvayre R, Douste-Blazy L, and Gatt S, Eds.). New York: Plenum, pp 809-822, 1988.
18. 18. Kornreich R, Desnick RJ, Bishop DF. Nucleotide sequence of the human α-galactosidase A gene. Nucleic Acids Res 17: 3301-3302, 1989.
19. 19. Wang A, Bishop D, Desnick R. Human α-N-acetylgalactosaminidase: Molecular cloning, nucleotide sequence, and expression of a full-length cDNA. J Biol Chem 265:21859-21866, 1990.
20. 20. Wang A, Desnick R. Structural organization and complete sequence of the human α-N-acetylgalactosaminidase gene: Homology with the α-galactosidase A gene proves evidence for evolution from a common ancestral gene. Genomics 10: 133-142, 1991.
21. 21. Schindler D, Bishop DF, Wolfe DE, Wang Am, Egge H, Lemieux RU, Desnick RJ. Neuroaxonal dystrophy due to lysosomal α-N-acetylgalactosaminidase deficiency. N Engl J Med 320:1735-1740, 1989.
22. 22. Kanzaki T, Wang AM, Desnick RJ. Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria. J Clin Invest 88:707-711, 1991.
23. 23. Gay C, Maire I, Piraud M, Blanchon Y, Lauras B, Desnick R. Schindler disease, α-N-acetylgalactosaminidase deficiency presenting as autism. Submitted for publication.
24. 24. Wolfe D, Schindler D, Desnick R. Neuroaxonal dystrophy in infantile alpha-N-acetylgalactosaminidase deficiency. J Neuropathol Exp Neurol 132:44-56, 1995.
25. 25. Chabas A, Coll MJ, Aparicio M, Rodriguez Diaz E. Mild phenotypic expression of alpha-N-acetylgalactosaminidase deficiency in two adult siblings. J Inherit Metab Dis 17:724-731, 1994.
26. 26. Kanzaki T, Yokota M, Irie F, Hirabayashi Y, Wang AM, Desnick RJ. Angiokeratoma corporis diffusum with glycopeptiduria due to deficient lysosomal α-N-acetylgalactosaminidase activity. Arch Dermatol 129:460-465, 1993.
27. 27. Wang A, Schindler D, Desnick RJ. Schindler disease: The molecular lesion in the α-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy. J Clin Invest 86:1752-1756, 1990.
28. 28. Keulemans JLM, Reuser AJJ, Froos MA, Willemsen R, Hermans MMP, van den Ouweland AMW, de Jong JGN, Wevers RA, Renier WO, Schindler D, Coll MJ, Chabas A, Sakuraba H, Suzuki Y, van Diggelen OP. Human α-N-acetylgalactosaminidase (α-NAGA) deficiency: New mutations and the paradox between genotype and phenotype. J Med Genet 33:458-465, 1996.
29. 29. Wang AM, Stewart CL, Desnick RJ. α-N-Acetylgalactosaminidase: Characterization of the murine cDNA and genomic sequences and generation of mice by targeted gene disruption. Am J Hum Genet 53:99, 1993.
30. 30. Wang AM, Stewart CL, Desnick RJ. Schindler disease: Generation of a murine model by targeted disruption of the α-N-acetylgalactosaminidase gene. Pediatr Res 35:155A, 1994.
31. 31. Chirgwin JM, Przybyla ARE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979.
32. 32. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467, 1977.
33. 33. Lehrach H, Diamond D, Wozney JM, Boedtker H. RNA Molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16:4743-4751, 1977.
34. 34. Ioannou YA, Zeidner KM, Grace ME, Desnick RJ. Human α-galactosidase A: Glycosylation site 3 is essential for enzyme solubility. Biochem J 332:789-797, 1998.
35. 35. Breathnach R, Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 50:349-383, 1981.
36. 36. Zhu A, Goldstein J. Cloning and characterization of a cDNA encoding chicken liver α-N-acetylgalactosaminidase. Gene 137:309-314, 1993.
37. 37. Wilson R, Ainscough R, Anderson K, Baynes C, Berks M, Bonfield J, Burton J, Connell M, Copsey T, Cooper J, et al. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature 368:32-38, 1994.
38. 38. Benson DA, Boguski MS, Lipman DJ, Ostell J, Ouellette BFF. GenBank. Nucleic Acids Res 26:1-7, 1998.
39. 39. Legler G. Glycoside hydrolases: Mechanistic information from studies with reversible and irreversible inhibitors. Adv Carbohydr Chem Biochem 48:319-380, 1990.